Clay Siegall is the co-founder and CEO of Seattle Genetics. Seattle Genetics is a cancer research company that is committed to making innovations in cancer therapy. Since 2012, the stock price of the company has been able to triple, thanks to the leadership of Clay Siegall. Clay has played a very significant role when it comes to the success and growth of Seattle Genetics. He believes that the treatment of cancer can be improved and the side effect of the medication made less adverse. The career of Clay Siegall is in biomedical studies and since he was young, he has always had passion for assisting patients who have cancer.
In 2002, Clay Siegall served as the chief executive officer of Seattle Genetics. Currently, he served as the chairman of the company’s board of directors. Seattle Genetics was started in the year 1998 after Clay Siegall saw the need to invest in cancer research. Clay has been working with the company for almost 20 years and has been able to contribute a lot to its growth. Over the years, Clay Siegall has worked hard in leading the company to achieve new cancer research and therapies to assist cancer patients. Clay Siegall is known all over the world as one of the individuals who are most passionate about cancer research and treatment.
Clay Siegall attributes part of the success that he now enjoys in his career to his impressive educational background. He attended the prestigious George Washington University and acquired his Ph.D. in Genetics. The research career of Dr. Clay Siegall started at the Bristol-Myers Squibb Pharmaceutical Research Institute. When he first joined the institute, Clay served as a senior research investigator and then moved to the position of the principal scientist. Clay Siegall has in the past worked at the National Cancer Institute as a staff fellow and biotechnology fellow. In 2012, Dr. Clay was the Pacific Northwest Ernst and Young Entrepreneur of the Year. In 2013, he was honored by the University of Maryland with the Alumnus of the Year for Natural Sciences, Math and Computer. All these awards are as a result of his significant contributions to scientific and medical communities.